GRIFOLS, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.26 EUR | +1.63% |
|
+11.24% | -33.58% |
| 09-16 | European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading | MT |
| 09-13 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biopharma | 3.99B | 4.24B | 3.81B | 5.01B | 5.56B | |||||
Total Assets | 8.43B | 7.98B | 9.5B | 13.23B | - | |||||
CAPEX | -868M | -289M | -350M | -403M | - | |||||
D&A | 196M | 201M | 228M | 294M | - | |||||
Operating Income | 1.08B | 950M | 659M | 791M | - | |||||
Bio Supplies | 267M | 224M | 226M | 146M | 160M | |||||
Total Assets | 277M | 298M | 101M | 342M | - | |||||
CAPEX | -65.45M | -10.92M | -13.84M | -98K | - | |||||
D&A | 20.42M | 21.85M | 2.95M | 5.76M | - | |||||
Operating Income | 16.25M | 19.87M | 45.99M | 114M | - | |||||
Raw Materials and Others | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostic | 734M | 776M | 779M | 671M | 670M | |||||
Total Assets | 3.68B | 3.37B | 3.51B | 3.68B | - | |||||
CAPEX | -104M | -34.52M | -19.99M | -49.89M | - | |||||
D&A | 52.22M | 63.05M | 88.56M | 64.68M | - | |||||
Operating Income | 216M | 216M | 153M | 130M | - | |||||
Pharmaceutical Contract Manufacturing Services | ||||||||||
Others | 22.82M | 31.99M | 39.62M | 250M | 203M | |||||
Total Assets | 132M | 2.21B | 2.47B | 2.68B | - | |||||
CAPEX | -1.77M | -1.15M | -15.98M | -30.19M | - | |||||
D&A | 2.15M | 2.82M | 6.98M | 20.37M | - | |||||
Operating Income | 1.28M | 2.24M | -58.6M | -46.81M | - | |||||
D&A | 19.65M | 20.28M | 21.1M | 22.9M | - | |||||
CAPEX | -73.54M | -107M | -55.38M | -59.87M | - | |||||
Total Assets | 1.07B | 1.19B | 3.42B | 1.61B | - | |||||
Operating Income | -169M | -184M | -185M | -219M | - | |||||
Intersegments | -52.18M | -53.11M | -67.55M | -8.95M | - | |||||
Total Assets | -32.89M | -26.77M | -39.96M | -7M | - | |||||
Operating Income | -3.09M | 4.43M | -10.9M | 35.42M | - | |||||
Pharmaceutical Products | ||||||||||
Hospital | 134M | 119M | 141M | - | - | |||||
Total Assets | 274M | 257M | 269M | - | - | |||||
CAPEX | -62.3M | -11.55M | -12.62M | - | - | |||||
D&A | 11.69M | 12.44M | 12.06M | - | - | |||||
Operating Income | -8.67M | -12.5M | -7.74M | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States + Canada | 3.39B | 3.6B | 3.15B | 3.86B | 3.9B | |||||
Total Assets | 9.06B | 9.14B | 10.53B | 11.56B | - | |||||
CAPEX | -788M | -253M | -296M | -363M | - | |||||
Rest of the World | 851M | 906M | 872M | 1.18B | 1.44B | |||||
Total Assets | 293M | 2.09B | 2.22B | 2.22B | - | |||||
CAPEX | -21.86M | -14.27M | -9.76M | -12.15M | - | |||||
European Union (Incl. Spain) | - | - | - | - | 1.26B | |||||
Unallocated Raw Material & Others | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Corporate | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Spain | 268M | 339M | 362M | 321M | - | |||||
Total Assets | 1.05B | 1.12B | 1.09B | 1.16B | - | |||||
CAPEX | -184M | -93.79M | -71.02M | -60.5M | - | |||||
Rest of European Union | 588M | 495M | 544M | 712M | - | |||||
Total Assets | 3.43B | 2.93B | 5.39B | 6.6B | - | |||||
CAPEX | -182M | -92.87M | -91.39M | -107M | - |
- Stock Market
- Equities
- GRF Stock
- Financials Grifols, S.A.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition